

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | skeletal muscle adaptation (GO:0043501) | 9.64517848 |
| 2 | plasma membrane repair (GO:0001778) | 8.84893788 |
| 3 | skeletal muscle fiber development (GO:0048741) | 8.53432943 |
| 4 | actin filament-based movement (GO:0030048) | 8.20948344 |
| 5 | skeletal muscle tissue regeneration (GO:0043403) | 7.48819797 |
| 6 | myotube cell development (GO:0014904) | 7.19458199 |
| 7 | striated muscle contraction (GO:0006941) | 6.71667017 |
| 8 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.68979121 |
| 9 | sarcomere organization (GO:0045214) | 6.40610809 |
| 10 | creatine metabolic process (GO:0006600) | 6.40285651 |
| 11 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.36983846 |
| 12 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 6.13804860 |
| 13 | glycogen catabolic process (GO:0005980) | 5.90804810 |
| 14 | striated muscle atrophy (GO:0014891) | 5.87590803 |
| 15 | cytidine metabolic process (GO:0046087) | 5.85712110 |
| 16 | cytidine catabolic process (GO:0006216) | 5.85712110 |
| 17 | cytidine deamination (GO:0009972) | 5.85712110 |
| 18 | muscle contraction (GO:0006936) | 5.84205583 |
| 19 | carnitine shuttle (GO:0006853) | 5.75496444 |
| 20 | response to inactivity (GO:0014854) | 5.72627573 |
| 21 | myofibril assembly (GO:0030239) | 5.61984928 |
| 22 | glucan catabolic process (GO:0009251) | 5.52618274 |
| 23 | response to muscle activity (GO:0014850) | 5.51228424 |
| 24 | purine nucleotide salvage (GO:0032261) | 5.49048738 |
| 25 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.31474702 |
| 26 | glucan biosynthetic process (GO:0009250) | 5.25638697 |
| 27 | glycogen biosynthetic process (GO:0005978) | 5.25638697 |
| 28 | regulation of cell communication by electrical coupling (GO:0010649) | 5.21318577 |
| 29 | muscle system process (GO:0003012) | 5.15185124 |
| 30 | muscle atrophy (GO:0014889) | 5.15023957 |
| 31 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.12133734 |
| 32 | cellular polysaccharide catabolic process (GO:0044247) | 5.11064688 |
| 33 | muscle fiber development (GO:0048747) | 5.03682012 |
| 34 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.01106751 |
| 35 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.00113657 |
| 36 | striated muscle adaptation (GO:0014888) | 4.94861853 |
| 37 | fatty acid transmembrane transport (GO:1902001) | 4.86887172 |
| 38 | polysaccharide catabolic process (GO:0000272) | 4.83186721 |
| 39 | cardiac myofibril assembly (GO:0055003) | 4.81569111 |
| 40 | carnitine transmembrane transport (GO:1902603) | 4.71725981 |
| 41 | IMP metabolic process (GO:0046040) | 4.66467850 |
| 42 | ubiquinone biosynthetic process (GO:0006744) | 4.59672842 |
| 43 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.55762138 |
| 44 | actomyosin structure organization (GO:0031032) | 4.55295781 |
| 45 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.44589706 |
| 46 | regulation of actin filament-based movement (GO:1903115) | 4.40161331 |
| 47 | glycogen metabolic process (GO:0005977) | 4.39874569 |
| 48 | carnitine transport (GO:0015879) | 4.35592223 |
| 49 | amino-acid betaine transport (GO:0015838) | 4.35592223 |
| 50 | glucan metabolic process (GO:0044042) | 4.30977411 |
| 51 | cellular glucan metabolic process (GO:0006073) | 4.30977411 |
| 52 | cardiac muscle hypertrophy (GO:0003300) | 4.29497888 |
| 53 | regulation of cofactor metabolic process (GO:0051193) | 4.10005876 |
| 54 | regulation of coenzyme metabolic process (GO:0051196) | 4.10005876 |
| 55 | striated muscle hypertrophy (GO:0014897) | 4.08851804 |
| 56 | ubiquinone metabolic process (GO:0006743) | 4.04799570 |
| 57 | NADH metabolic process (GO:0006734) | 4.04794215 |
| 58 | response to activity (GO:0014823) | 4.02229739 |
| 59 | muscle cell fate commitment (GO:0042693) | 4.01781031 |
| 60 | muscle adaptation (GO:0043500) | 4.01178814 |
| 61 | skeletal muscle tissue development (GO:0007519) | 4.00496931 |
| 62 | muscle organ development (GO:0007517) | 3.96203354 |
| 63 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.95908914 |
| 64 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.95221977 |
| 65 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.93424102 |
| 66 | adult heart development (GO:0007512) | 3.92130478 |
| 67 | tricarboxylic acid cycle (GO:0006099) | 3.91837125 |
| 68 | muscle structure development (GO:0061061) | 3.91266232 |
| 69 | 2-oxoglutarate metabolic process (GO:0006103) | 3.89479088 |
| 70 | muscle organ morphogenesis (GO:0048644) | 3.86673812 |
| 71 | myotube differentiation (GO:0014902) | 3.83151561 |
| 72 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.82903953 |
| 73 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.81611021 |
| 74 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.80431358 |
| 75 | striated muscle cell development (GO:0055002) | 3.79295204 |
| 76 | regulation of myoblast differentiation (GO:0045661) | 3.77828233 |
| 77 | muscle cell cellular homeostasis (GO:0046716) | 3.74539202 |
| 78 | muscle hypertrophy (GO:0014896) | 3.73551173 |
| 79 | fructose metabolic process (GO:0006000) | 3.67849170 |
| 80 | quinone biosynthetic process (GO:1901663) | 3.67189917 |
| 81 | negative regulation of muscle hypertrophy (GO:0014741) | 3.65999052 |
| 82 | muscle tissue morphogenesis (GO:0060415) | 3.63480291 |
| 83 | skeletal muscle cell differentiation (GO:0035914) | 3.57727544 |
| 84 | AMP metabolic process (GO:0046033) | 3.56969451 |
| 85 | IMP biosynthetic process (GO:0006188) | 3.56070983 |
| 86 | cardiac muscle contraction (GO:0060048) | 3.55183515 |
| 87 | neuromuscular synaptic transmission (GO:0007274) | 3.53229677 |
| 88 | cellular carbohydrate catabolic process (GO:0044275) | 3.50824501 |
| 89 | neuronal action potential propagation (GO:0019227) | 3.49221619 |
| 90 | regulation of relaxation of muscle (GO:1901077) | 3.48312912 |
| 91 | cellular response to dexamethasone stimulus (GO:0071549) | 3.42353074 |
| 92 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.39007100 |
| 93 | regulation of sulfur metabolic process (GO:0042762) | 3.37608043 |
| 94 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.37426912 |
| 95 | gluconeogenesis (GO:0006094) | 3.34096049 |
| 96 | positive regulation of myotube differentiation (GO:0010831) | 3.29586420 |
| 97 | cardiac muscle adaptation (GO:0014887) | 3.28423396 |
| 98 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.28423396 |
| 99 | muscle hypertrophy in response to stress (GO:0003299) | 3.28423396 |
| 100 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.25136898 |
| 101 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.24976131 |
| 102 | heart process (GO:0003015) | 3.23484178 |
| 103 | heart contraction (GO:0060047) | 3.23484178 |
| 104 | muscle cell development (GO:0055001) | 3.22551260 |
| 105 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.21373062 |
| 106 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.21373062 |
| 107 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.21179869 |
| 108 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.21179869 |
| 109 | myoblast fusion (GO:0007520) | 3.21095277 |
| 110 | response to dexamethasone (GO:0071548) | 3.19109686 |
| 111 | positive regulation of cation channel activity (GO:2001259) | 3.19048758 |
| 112 | striated muscle tissue development (GO:0014706) | 3.17771345 |
| 113 | oxidative phosphorylation (GO:0006119) | 3.16567827 |
| 114 | neuromuscular junction development (GO:0007528) | 3.11977755 |
| 115 | positive regulation of myoblast differentiation (GO:0045663) | 3.08935614 |
| 116 | regulation of sequestering of triglyceride (GO:0010889) | 3.08928611 |
| 117 | quaternary ammonium group transport (GO:0015697) | 3.06180054 |
| 118 | cellular polysaccharide biosynthetic process (GO:0033692) | 3.05648661 |
| 119 | negative regulation of muscle contraction (GO:0045932) | 3.04277617 |
| 120 | cellular polysaccharide metabolic process (GO:0044264) | 3.03363669 |
| 121 | regulation of striated muscle contraction (GO:0006942) | 3.02750964 |
| 122 | muscle filament sliding (GO:0030049) | 13.5036998 |
| 123 | actin-myosin filament sliding (GO:0033275) | 13.5036998 |
| 124 | regulation of skeletal muscle contraction (GO:0014819) | 11.7752486 |
| 125 | skeletal muscle contraction (GO:0003009) | 11.7221421 |
| 126 | actin-mediated cell contraction (GO:0070252) | 11.0430600 |
| 127 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 10.7188300 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.54958226 |
| 2 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.30789061 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.94274704 |
| 4 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.40366503 |
| 5 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.19347604 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.87817099 |
| 7 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.79898855 |
| 8 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.78270598 |
| 9 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.73384668 |
| 10 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.72346728 |
| 11 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.72346728 |
| 12 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.43668675 |
| 13 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.41483150 |
| 14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.20885525 |
| 15 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.18128614 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.10463752 |
| 17 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.10026950 |
| 18 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.08739650 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.92035687 |
| 20 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.88009694 |
| 21 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.87448073 |
| 22 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.85210271 |
| 23 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.83041614 |
| 24 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.77068341 |
| 25 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.71769699 |
| 26 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.67323323 |
| 27 | VDR_22108803_ChIP-Seq_LS180_Human | 1.67043662 |
| 28 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63849684 |
| 29 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.63167263 |
| 30 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.63167263 |
| 31 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.59938352 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.59086626 |
| 33 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.55999614 |
| 34 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.53771723 |
| 35 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.51860195 |
| 36 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.49844016 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.48673467 |
| 38 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.48441793 |
| 39 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.45682197 |
| 40 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.44695871 |
| 41 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.43956419 |
| 42 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.43806948 |
| 43 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.43653268 |
| 44 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.42669132 |
| 45 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.41948435 |
| 46 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.41181123 |
| 47 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.40191337 |
| 48 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.36537115 |
| 49 | SA1_27219007_Chip-Seq_Bcells_Human | 1.35035003 |
| 50 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.34691848 |
| 51 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.34606779 |
| 52 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.34175349 |
| 53 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.32826437 |
| 54 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.31472046 |
| 55 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.31406869 |
| 56 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.31218730 |
| 57 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.30374033 |
| 58 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.29585531 |
| 59 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.27146108 |
| 60 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.25591564 |
| 61 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.24712521 |
| 62 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.22949421 |
| 63 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 1.22944166 |
| 64 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.21945995 |
| 65 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.19998194 |
| 66 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.19540794 |
| 67 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.17129313 |
| 68 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.16300608 |
| 69 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.14926277 |
| 70 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.13007063 |
| 71 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.12629024 |
| 72 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12114666 |
| 73 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.11354745 |
| 74 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11251128 |
| 75 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10936250 |
| 76 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.10642148 |
| 77 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.10134290 |
| 78 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.07810416 |
| 79 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.06413520 |
| 80 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.05904994 |
| 81 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.05224773 |
| 82 | CBP_21632823_ChIP-Seq_H3396_Human | 1.02572514 |
| 83 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.01758608 |
| 84 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.00534853 |
| 85 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.98871484 |
| 86 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.98486101 |
| 87 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.98377246 |
| 88 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.97920452 |
| 89 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.97588875 |
| 90 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.97566307 |
| 91 | P68_20966046_ChIP-Seq_HELA_Human | 0.97422551 |
| 92 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 0.97335369 |
| 93 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.96993034 |
| 94 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.96530402 |
| 95 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.95192547 |
| 96 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.95076198 |
| 97 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.94332264 |
| 98 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.93474846 |
| 99 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.93466599 |
| 100 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.93271461 |
| 101 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.92808030 |
| 102 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.92032637 |
| 103 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.90863720 |
| 104 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.90434456 |
| 105 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.90166327 |
| 106 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.89986309 |
| 107 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.89886909 |
| 108 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.89649117 |
| 109 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.89598846 |
| 110 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.88967698 |
| 111 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.88167618 |
| 112 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.88083357 |
| 113 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.88012521 |
| 114 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.87401345 |
| 115 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.86554193 |
| 116 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.85259038 |
| 117 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.85173162 |
| 118 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.84646357 |
| 119 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.84645714 |
| 120 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.83867980 |
| 121 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83762947 |
| 122 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.83486424 |
| 123 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.83058865 |
| 124 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82932922 |
| 125 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.82878344 |
| 126 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.82246775 |
| 127 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.81544525 |
| 128 | NCOR_22424771_ChIP-Seq_293T_Human | 0.81415784 |
| 129 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.81227351 |
| 130 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.81179419 |
| 131 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.80993389 |
| 132 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.80606783 |
| 133 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.79535898 |
| 134 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.77612640 |
| 135 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.77445037 |
| 136 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.76889464 |
| 137 | P300_27268052_Chip-Seq_Bcells_Human | 0.76570921 |
| 138 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.76320131 |
| 139 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.75373440 |
| 140 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.74578626 |
| 141 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.72871684 |
| 142 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.72871684 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 7.90977525 |
| 2 | MP0003646_muscle_fatigue | 6.38288652 |
| 3 | MP0000749_muscle_degeneration | 6.29107369 |
| 4 | MP0000751_myopathy | 5.59519235 |
| 5 | MP0000747_muscle_weakness | 4.63659929 |
| 6 | MP0002106_abnormal_muscle_physiology | 4.22432744 |
| 7 | MP0004036_abnormal_muscle_relaxation | 3.87074341 |
| 8 | MP0000759_abnormal_skeletal_muscle | 3.83710954 |
| 9 | MP0005451_abnormal_body_composition | 3.80276213 |
| 10 | MP0005369_muscle_phenotype | 3.58493653 |
| 11 | MP0002269_muscular_atrophy | 3.52519955 |
| 12 | MP0004087_abnormal_muscle_fiber | 3.51568984 |
| 13 | MP0002837_dystrophic_cardiac_calcinosis | 3.44055470 |
| 14 | MP0004130_abnormal_muscle_cell | 3.31614174 |
| 15 | MP0000750_abnormal_muscle_regeneration | 3.23506211 |
| 16 | MP0005620_abnormal_muscle_contractility | 3.01865116 |
| 17 | MP0004233_abnormal_muscle_weight | 2.82520951 |
| 18 | MP0000733_abnormal_muscle_development | 2.76984305 |
| 19 | MP0002108_abnormal_muscle_morphology | 2.27624762 |
| 20 | MP0000013_abnormal_adipose_tissue | 2.20389202 |
| 21 | MP0002332_abnormal_exercise_endurance | 2.07215673 |
| 22 | MP0005330_cardiomyopathy | 1.98976052 |
| 23 | MP0006036_abnormal_mitochondrial_physio | 1.98791171 |
| 24 | MP0004270_analgesia | 1.65743426 |
| 25 | MP0004084_abnormal_cardiac_muscle | 1.63166147 |
| 26 | MP0002971_abnormal_brown_adipose | 1.57944463 |
| 27 | MP0004185_abnormal_adipocyte_glucose | 1.53235800 |
| 28 | MP0004215_abnormal_myocardial_fiber | 1.42232589 |
| 29 | MP0005666_abnormal_adipose_tissue | 1.42000477 |
| 30 | MP0004484_altered_response_of | 1.36339155 |
| 31 | MP0002972_abnormal_cardiac_muscle | 1.32934189 |
| 32 | MP0005375_adipose_tissue_phenotype | 1.32230112 |
| 33 | MP0010630_abnormal_cardiac_muscle | 1.22161956 |
| 34 | MP0003221_abnormal_cardiomyocyte_apopto | 1.18976310 |
| 35 | MP0000003_abnormal_adipose_tissue | 1.16239334 |
| 36 | MP0002822_catalepsy | 1.16073087 |
| 37 | MP0001661_extended_life_span | 1.07019968 |
| 38 | MP0003806_abnormal_nucleotide_metabolis | 1.07002875 |
| 39 | MP0005266_abnormal_metabolism | 1.04337805 |
| 40 | MP0003950_abnormal_plasma_membrane | 1.02969399 |
| 41 | MP0006035_abnormal_mitochondrial_morpho | 1.00315670 |
| 42 | MP0004134_abnormal_chest_morphology | 0.94844517 |
| 43 | MP0002234_abnormal_pharynx_morphology | 0.92126446 |
| 44 | MP0001544_abnormal_cardiovascular_syste | 0.86703517 |
| 45 | MP0005385_cardiovascular_system_phenoty | 0.86703517 |
| 46 | MP0002876_abnormal_thyroid_physiology | 0.84064114 |
| 47 | MP0003705_abnormal_hypodermis_morpholog | 0.81264698 |
| 48 | MP0004043_abnormal_pH_regulation | 0.76235430 |
| 49 | MP0005410_abnormal_fertilization | 0.74611205 |
| 50 | MP0003137_abnormal_impulse_conducting | 0.74234913 |
| 51 | MP0003656_abnormal_erythrocyte_physiolo | 0.72553846 |
| 52 | MP0004147_increased_porphyrin_level | 0.71190052 |
| 53 | MP0009250_abnormal_appendicular_skeleto | 0.67561643 |
| 54 | MP0001299_abnormal_eye_distance/ | 0.66881093 |
| 55 | MP0000762_abnormal_tongue_morphology | 0.65656739 |
| 56 | MP0005670_abnormal_white_adipose | 0.63035836 |
| 57 | MP0002078_abnormal_glucose_homeostasis | 0.62903921 |
| 58 | MP0000372_irregular_coat_pigmentation | 0.62067219 |
| 59 | MP0005332_abnormal_amino_acid | 0.57403119 |
| 60 | MP0005334_abnormal_fat_pad | 0.55687967 |
| 61 | MP0008961_abnormal_basal_metabolism | 0.54946564 |
| 62 | MP0002638_abnormal_pupillary_reflex | 0.53081253 |
| 63 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.52277614 |
| 64 | MP0005167_abnormal_blood-brain_barrier | 0.51454330 |
| 65 | MP0000266_abnormal_heart_morphology | 0.51121301 |
| 66 | MP0000343_altered_response_to | 0.48802801 |
| 67 | MP0003959_abnormal_lean_body | 0.48637543 |
| 68 | MP0009780_abnormal_chondrocyte_physiolo | 0.48216916 |
| 69 | MP0005452_abnormal_adipose_tissue | 0.47913060 |
| 70 | MP0005645_abnormal_hypothalamus_physiol | 0.45473085 |
| 71 | MP0008569_lethality_at_weaning | 0.41928665 |
| 72 | MP0003045_fibrosis | 0.41769140 |
| 73 | MP0009672_abnormal_birth_weight | 0.41509806 |
| 74 | MP0002127_abnormal_cardiovascular_syste | 0.41508555 |
| 75 | MP0001986_abnormal_taste_sensitivity | 0.40977371 |
| 76 | MP0008775_abnormal_heart_ventricle | 0.40295361 |
| 77 | MP0006138_congestive_heart_failure | 0.39775097 |
| 78 | MP0003879_abnormal_hair_cell | 0.39380612 |
| 79 | MP0002896_abnormal_bone_mineralization | 0.38720068 |
| 80 | MP0005275_abnormal_skin_tensile | 0.37471533 |
| 81 | MP0002114_abnormal_axial_skeleton | 0.37466340 |
| 82 | MP0005319_abnormal_enzyme/_coenzyme | 0.34588280 |
| 83 | MP0001849_ear_inflammation | 0.34570542 |
| 84 | MP0004381_abnormal_hair_follicle | 0.32600694 |
| 85 | MP0005083_abnormal_biliary_tract | 0.32147002 |
| 86 | MP0003948_abnormal_gas_homeostasis | 0.31286471 |
| 87 | MP0005423_abnormal_somatic_nervous | 0.31229212 |
| 88 | MP0002067_abnormal_sensory_capabilities | 0.30899243 |
| 89 | MP0000569_abnormal_digit_pigmentation | 0.30850217 |
| 90 | MP0002734_abnormal_mechanical_nocicepti | 0.30402999 |
| 91 | MP0008872_abnormal_physiological_respon | 0.29193865 |
| 92 | MP0005166_decreased_susceptibility_to | 0.28012679 |
| 93 | MP0000579_abnormal_nail_morphology | 0.27925214 |
| 94 | MP0009115_abnormal_fat_cell | 0.27735643 |
| 95 | MP0002009_preneoplasia | 0.27203373 |
| 96 | MP0005535_abnormal_body_temperature | 0.27019216 |
| 97 | MP0002089_abnormal_postnatal_growth/wei | 0.26992108 |
| 98 | MP0002118_abnormal_lipid_homeostasis | 0.25096336 |
| 99 | MP0001440_abnormal_grooming_behavior | 0.25021414 |
| 100 | MP0002066_abnormal_motor_capabilities/c | 0.24973133 |
| 101 | MP0000230_abnormal_systemic_arterial | 0.24843366 |
| 102 | MP0005376_homeostasis/metabolism_phenot | 0.24475859 |
| 103 | MP0004142_abnormal_muscle_tone | 0.23922442 |
| 104 | MP0005386_behavior/neurological_phenoty | 0.23817945 |
| 105 | MP0004924_abnormal_behavior | 0.23817945 |
| 106 | MP0004085_abnormal_heartbeat | 0.23576887 |
| 107 | MP0000383_abnormal_hair_follicle | 0.23077500 |
| 108 | MP0004510_myositis | 0.22024511 |
| 109 | MP0001485_abnormal_pinna_reflex | 0.22010339 |
| 110 | MP0001943_abnormal_respiration | 0.22007007 |
| 111 | MP0005503_abnormal_tendon_morphology | 0.21733545 |
| 112 | MP0006276_abnormal_autonomic_nervous | 0.20130776 |
| 113 | MP0009379_abnormal_foot_pigmentation | 0.19900619 |
| 114 | MP0003828_pulmonary_edema | 0.19797066 |
| 115 | MP0001765_abnormal_ion_homeostasis | 0.19748131 |
| 116 | MP0004197_abnormal_fetal_growth/weight/ | 0.19558574 |
| 117 | MP0005187_abnormal_penis_morphology | 0.19169342 |
| 118 | MP0000427_abnormal_hair_cycle | 0.18889325 |
| 119 | MP0001502_abnormal_circadian_rhythm | 0.18835023 |
| 120 | MP0003195_calcinosis | 0.18668025 |
| 121 | MP0001346_abnormal_lacrimal_gland | 0.17984794 |
| 122 | MP0002970_abnormal_white_adipose | 0.16971460 |
| 123 | MP0001243_abnormal_dermal_layer | 0.16923430 |
| 124 | MP0002877_abnormal_melanocyte_morpholog | 0.16807457 |
| 125 | MP0001853_heart_inflammation | 0.16174136 |
| 126 | MP0002128_abnormal_blood_circulation | 0.16099567 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type 1 muscle fiber predominance (HP:0003803) | 8.43729381 |
| 2 | Exercise-induced myalgia (HP:0003738) | 8.04778031 |
| 3 | Distal arthrogryposis (HP:0005684) | 7.23672494 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 7.04578007 |
| 5 | Myopathic facies (HP:0002058) | 6.78457449 |
| 6 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.01700939 |
| 7 | Ulnar deviation of the wrist (HP:0003049) | 5.94885906 |
| 8 | Round ear (HP:0100830) | 5.93629318 |
| 9 | Calf muscle hypertrophy (HP:0008981) | 5.41002186 |
| 10 | Muscle fiber splitting (HP:0003555) | 5.22982167 |
| 11 | Hyporeflexia of lower limbs (HP:0002600) | 5.16604423 |
| 12 | Calcaneovalgus deformity (HP:0001848) | 5.13907286 |
| 13 | Difficulty running (HP:0009046) | 5.05383738 |
| 14 | Deformed tarsal bones (HP:0008119) | 4.88845329 |
| 15 | Myoglobinuria (HP:0002913) | 4.78884653 |
| 16 | Absent phalangeal crease (HP:0006109) | 4.67440411 |
| 17 | EMG: myopathic abnormalities (HP:0003458) | 4.50520405 |
| 18 | Muscle stiffness (HP:0003552) | 4.47698503 |
| 19 | Rhabdomyolysis (HP:0003201) | 4.01968396 |
| 20 | Abnormal finger flexion creases (HP:0006143) | 3.97761644 |
| 21 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.91891964 |
| 22 | Increased connective tissue (HP:0009025) | 3.88378317 |
| 23 | Abnormality of the calf musculature (HP:0001430) | 3.78003502 |
| 24 | Neck muscle weakness (HP:0000467) | 3.77032245 |
| 25 | Myotonia (HP:0002486) | 3.66078807 |
| 26 | Rimmed vacuoles (HP:0003805) | 3.58264139 |
| 27 | Malignant hyperthermia (HP:0002047) | 3.49241026 |
| 28 | Frequent falls (HP:0002359) | 3.42771279 |
| 29 | Increased variability in muscle fiber diameter (HP:0003557) | 3.38013486 |
| 30 | Areflexia of lower limbs (HP:0002522) | 3.35722658 |
| 31 | Difficulty climbing stairs (HP:0003551) | 3.14044826 |
| 32 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.09507306 |
| 33 | Subaortic stenosis (HP:0001682) | 3.09507306 |
| 34 | Abnormality of the calcaneus (HP:0008364) | 3.06041431 |
| 35 | Pelvic girdle muscle weakness (HP:0003749) | 3.02720604 |
| 36 | Shoulder girdle muscle weakness (HP:0003547) | 3.01706727 |
| 37 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.93437511 |
| 38 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.93437511 |
| 39 | Fatigable weakness (HP:0003473) | 2.83570652 |
| 40 | Abnormality of the neuromuscular junction (HP:0003398) | 2.83570652 |
| 41 | Hyperkalemia (HP:0002153) | 2.76527193 |
| 42 | Asymmetric septal hypertrophy (HP:0001670) | 2.74319331 |
| 43 | Progressive muscle weakness (HP:0003323) | 2.72693229 |
| 44 | Bundle branch block (HP:0011710) | 2.67396568 |
| 45 | Slender build (HP:0001533) | 2.64935464 |
| 46 | EMG: neuropathic changes (HP:0003445) | 2.64297686 |
| 47 | Distal lower limb muscle weakness (HP:0009053) | 2.57573203 |
| 48 | Bulbar palsy (HP:0001283) | 2.54293650 |
| 49 | Generalized muscle weakness (HP:0003324) | 2.47252028 |
| 50 | Weak cry (HP:0001612) | 2.44328832 |
| 51 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.41125920 |
| 52 | Facial diplegia (HP:0001349) | 2.38209273 |
| 53 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.35264722 |
| 54 | Gowers sign (HP:0003391) | 2.33792530 |
| 55 | Proximal amyotrophy (HP:0007126) | 2.31174641 |
| 56 | Spinal rigidity (HP:0003306) | 2.30419678 |
| 57 | Paralysis (HP:0003470) | 2.29952694 |
| 58 | Fetal akinesia sequence (HP:0001989) | 2.29332967 |
| 59 | Muscular dystrophy (HP:0003560) | 2.26109055 |
| 60 | Sudden death (HP:0001699) | 2.22708187 |
| 61 | Scapular winging (HP:0003691) | 2.22339015 |
| 62 | Nonprogressive disorder (HP:0003680) | 2.20247109 |
| 63 | Ulnar deviation of finger (HP:0009465) | 2.13788265 |
| 64 | Limb-girdle muscle weakness (HP:0003325) | 2.12858192 |
| 65 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.11003467 |
| 66 | Hip contracture (HP:0003273) | 2.07733198 |
| 67 | Exercise intolerance (HP:0003546) | 2.05735026 |
| 68 | Muscle fiber inclusion bodies (HP:0100299) | 11.6621246 |
| 69 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 10.8986035 |
| 70 | Nemaline bodies (HP:0003798) | 10.5143199 |
| 71 | Limb-girdle muscle atrophy (HP:0003797) | 1.99281753 |
| 72 | Waddling gait (HP:0002515) | 1.94099296 |
| 73 | Metatarsus adductus (HP:0001840) | 1.89019426 |
| 74 | Increased intramyocellular lipid droplets (HP:0012240) | 1.88448934 |
| 75 | Distal lower limb amyotrophy (HP:0008944) | 1.87026721 |
| 76 | Hypoplastic ischia (HP:0003175) | 1.86950979 |
| 77 | Achilles tendon contracture (HP:0001771) | 1.81483635 |
| 78 | Long clavicles (HP:0000890) | 1.80997463 |
| 79 | Increased muscle lipid content (HP:0009058) | 1.77636465 |
| 80 | Heart block (HP:0012722) | 1.71817970 |
| 81 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.71419829 |
| 82 | Type 2 muscle fiber atrophy (HP:0003554) | 1.70404862 |
| 83 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.69710880 |
| 84 | Abnormality of the Achilles tendon (HP:0005109) | 1.65059395 |
| 85 | Ragged-red muscle fibers (HP:0003200) | 1.63141318 |
| 86 | Abnormality of the ischium (HP:0003174) | 1.61634341 |
| 87 | Tarsal synostosis (HP:0008368) | 1.61591362 |
| 88 | Popliteal pterygium (HP:0009756) | 1.59406905 |
| 89 | Ventricular tachycardia (HP:0004756) | 1.59076233 |
| 90 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.58759093 |
| 91 | Abnormal atrioventricular conduction (HP:0005150) | 1.55528084 |
| 92 | Easy fatigability (HP:0003388) | 1.53135461 |
| 93 | Muscle fiber atrophy (HP:0100295) | 1.52526702 |
| 94 | Adducted thumb (HP:0001181) | 1.51587430 |
| 95 | Dilated cardiomyopathy (HP:0001644) | 1.47107688 |
| 96 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.44703929 |
| 97 | Synostosis involving bones of the feet (HP:0009140) | 1.44703929 |
| 98 | Congenital hip dislocation (HP:0001374) | 1.42890436 |
| 99 | Lower limb amyotrophy (HP:0007210) | 1.42750477 |
| 100 | Abnormality of placental membranes (HP:0011409) | 1.41164059 |
| 101 | Amniotic constriction ring (HP:0009775) | 1.41164059 |
| 102 | Abnormality of potassium homeostasis (HP:0011042) | 1.40543165 |
| 103 | Short palpebral fissure (HP:0012745) | 1.39498238 |
| 104 | Stridor (HP:0010307) | 1.39216302 |
| 105 | Limited hip movement (HP:0008800) | 1.38750366 |
| 106 | Ventricular arrhythmia (HP:0004308) | 1.37759105 |
| 107 | Lipoatrophy (HP:0100578) | 1.37029919 |
| 108 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.36931176 |
| 109 | Cholelithiasis (HP:0001081) | 1.36715970 |
| 110 | Hyperuricemia (HP:0002149) | 1.36612482 |
| 111 | Increased purine levels (HP:0004368) | 1.36612482 |
| 112 | Foot dorsiflexor weakness (HP:0009027) | 1.36597495 |
| 113 | Acute necrotizing encephalopathy (HP:0006965) | 1.34137382 |
| 114 | Oligomenorrhea (HP:0000876) | 1.33040737 |
| 115 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.32394846 |
| 116 | Abnormality of the foot musculature (HP:0001436) | 1.31545281 |
| 117 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.28669860 |
| 118 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.20803719 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.29925272 |
| 2 | PHKG2 | 4.54945418 |
| 3 | PHKG1 | 4.54945418 |
| 4 | PIK3CG | 4.02349649 |
| 5 | NME1 | 3.94851362 |
| 6 | PDK4 | 2.81864508 |
| 7 | PDK3 | 2.81864508 |
| 8 | MAP2K3 | 2.56951515 |
| 9 | NEK1 | 2.04991752 |
| 10 | MAP3K7 | 2.04040051 |
| 11 | MUSK | 2.02440027 |
| 12 | PINK1 | 2.00293984 |
| 13 | OBSCN | 10.5117651 |
| 14 | TRIB3 | 1.98594746 |
| 15 | PDK2 | 1.78523443 |
| 16 | DMPK | 1.75496281 |
| 17 | MAPK12 | 1.44336831 |
| 18 | BCKDK | 1.41826071 |
| 19 | MAP2K4 | 1.38233605 |
| 20 | PIK3CA | 1.28454968 |
| 21 | MAP2K6 | 1.24634674 |
| 22 | MAP3K13 | 1.12007221 |
| 23 | KIT | 1.01873581 |
| 24 | MAP3K3 | 0.93823226 |
| 25 | AKT2 | 0.79751980 |
| 26 | MAPK13 | 0.75574534 |
| 27 | PRKAA1 | 0.73041561 |
| 28 | NEK9 | 0.71920455 |
| 29 | MAPKAPK3 | 0.71399558 |
| 30 | PKN2 | 0.69813896 |
| 31 | MAPK15 | 0.69395939 |
| 32 | EPHB1 | 0.68171397 |
| 33 | PRKAA2 | 0.65037326 |
| 34 | RPS6KB2 | 0.64970539 |
| 35 | CAMK2G | 0.64665848 |
| 36 | CAMK4 | 0.64006399 |
| 37 | LIMK1 | 0.62873355 |
| 38 | ERBB3 | 0.59431987 |
| 39 | MARK1 | 0.56914486 |
| 40 | ZAK | 0.55695733 |
| 41 | MAPK11 | 0.52976343 |
| 42 | TAOK2 | 0.50596039 |
| 43 | TBK1 | 0.49880175 |
| 44 | CAMK1 | 0.49557543 |
| 45 | TAOK3 | 0.47444596 |
| 46 | TRPM7 | 0.46518202 |
| 47 | ILK | 0.45098485 |
| 48 | MAP3K11 | 0.44939387 |
| 49 | RIPK1 | 0.43381158 |
| 50 | TAOK1 | 0.41649017 |
| 51 | STK24 | 0.39707557 |
| 52 | PTK6 | 0.39459635 |
| 53 | MARK3 | 0.38300638 |
| 54 | CAMK2A | 0.36729479 |
| 55 | PNCK | 0.35702508 |
| 56 | FRK | 0.34634575 |
| 57 | TNK2 | 0.34444229 |
| 58 | PRKD3 | 0.33656612 |
| 59 | TLK1 | 0.33192867 |
| 60 | STK16 | 0.32539680 |
| 61 | ICK | 0.32410094 |
| 62 | RPS6KB1 | 0.31473313 |
| 63 | PKN1 | 0.31022309 |
| 64 | CDK19 | 0.29786413 |
| 65 | MOS | 0.29361905 |
| 66 | TEC | 0.26584646 |
| 67 | MAP3K10 | 0.26114417 |
| 68 | MAP3K6 | 0.25652916 |
| 69 | PRKG1 | 0.24963864 |
| 70 | RPS6KA6 | 0.24927350 |
| 71 | DAPK2 | 0.24827204 |
| 72 | RIPK4 | 0.24458680 |
| 73 | SYK | 0.24438906 |
| 74 | MAP2K1 | 0.23923464 |
| 75 | PRKCQ | 0.23706834 |
| 76 | CCNB1 | 0.23639955 |
| 77 | GRK1 | 0.23617515 |
| 78 | PDPK1 | 0.22804531 |
| 79 | EEF2K | 0.22691255 |
| 80 | PDK1 | 0.22685138 |
| 81 | SGK1 | 0.21895315 |
| 82 | PTK2B | 0.21542061 |
| 83 | PRKACB | 0.20555477 |
| 84 | FLT3 | 0.20413099 |
| 85 | MAPK4 | 0.20401086 |
| 86 | ZAP70 | 0.19964487 |
| 87 | MAP3K5 | 0.19163563 |
| 88 | SIK1 | 0.19060120 |
| 89 | DYRK1B | 0.18312533 |
| 90 | RPS6KA3 | 0.18208811 |
| 91 | RPS6KL1 | 0.17877291 |
| 92 | RPS6KC1 | 0.17877291 |
| 93 | TYK2 | 0.17344307 |
| 94 | CSF1R | 0.17204128 |
| 95 | MAPKAPK5 | 0.17176597 |
| 96 | ROCK1 | 0.17136229 |
| 97 | MAP3K1 | 0.16748580 |
| 98 | MAP4K2 | 0.15951623 |
| 99 | ADRBK2 | 0.15827909 |
| 100 | KSR2 | 0.15269801 |
| 101 | CAMK2D | 0.14159623 |
| 102 | ERN1 | 0.12105008 |
| 103 | PRKACA | 0.11923698 |
| 104 | LATS1 | 0.10781752 |
| 105 | MAPK7 | 0.10723215 |
| 106 | BMPR1B | 0.10687210 |
| 107 | MAPK3 | 0.09218310 |
| 108 | TXK | 0.07344771 |
| 109 | PAK6 | 0.07038182 |
| 110 | IKBKB | 0.06822810 |
| 111 | PRKD1 | 0.06663259 |
| 112 | MAP2K2 | 0.06493145 |
| 113 | LRRK2 | 0.06154864 |
| 114 | CDK4 | 0.05884325 |
| 115 | TIE1 | 0.05783415 |
| 116 | DYRK3 | 0.05514484 |
| 117 | GSK3A | 0.05484098 |
| 118 | MAPK10 | 0.04625765 |
| 119 | NME2 | 0.03549306 |
| 120 | STK38 | 0.03222602 |
| 121 | MTOR | 0.02917330 |
| 122 | TGFBR2 | 0.02759527 |
| 123 | INSRR | 0.02449275 |
| 124 | JAK2 | -3.7008208 |
| 125 | MAPKAPK2 | -0.0514711 |
| 126 | ROCK2 | -0.0484417 |
| 127 | FGFR4 | -0.0475540 |
| 128 | PRKDC | -0.0467344 |
| 129 | STK39 | -0.0463978 |
| 130 | CAMK2B | -0.0414001 |
| 131 | RET | -0.0390241 |
| 132 | WNK1 | -0.0371102 |
| 133 | PRKACG | -0.0200394 |
| 134 | TESK1 | -0.0157933 |
| 135 | LATS2 | -0.0138628 |
| 136 | STK11 | -0.0119328 |
| 137 | CSNK1D | -0.0098429 |
| 138 | RPS6KA1 | -0.0030726 |
| 139 | MAPK8 | -0.0030424 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.59605720 |
| 2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.21882483 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.89571038 |
| 4 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.54886943 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.39682523 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.19767638 |
| 7 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 3.00718527 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.75986573 |
| 9 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.50294780 |
| 10 | Carbon metabolism_Homo sapiens_hsa01200 | 2.32723120 |
| 11 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.30499391 |
| 12 | Insulin signaling pathway_Homo sapiens_hsa04910 | 2.26330640 |
| 13 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.17961973 |
| 14 | Insulin resistance_Homo sapiens_hsa04931 | 2.10842305 |
| 15 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.07744940 |
| 16 | Circadian rhythm_Homo sapiens_hsa04710 | 2.05139568 |
| 17 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.91156045 |
| 18 | Parkinsons disease_Homo sapiens_hsa05012 | 1.88119384 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.75395985 |
| 20 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.74846899 |
| 21 | Alzheimers disease_Homo sapiens_hsa05010 | 1.67585473 |
| 22 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.64855762 |
| 23 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.64319961 |
| 24 | Galactose metabolism_Homo sapiens_hsa00052 | 1.61158808 |
| 25 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.60110669 |
| 26 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.57944018 |
| 27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.53784861 |
| 28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.52837683 |
| 29 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.40153757 |
| 30 | Tight junction_Homo sapiens_hsa04530 | 1.39389174 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.38981480 |
| 32 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.37437956 |
| 33 | Viral myocarditis_Homo sapiens_hsa05416 | 1.30574311 |
| 34 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.27976524 |
| 35 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.23494379 |
| 36 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.14385350 |
| 37 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.12761634 |
| 38 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.08535050 |
| 39 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.06709821 |
| 40 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.98774328 |
| 41 | Huntingtons disease_Homo sapiens_hsa05016 | 0.96934430 |
| 42 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.92733814 |
| 43 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.88177376 |
| 44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.87359929 |
| 45 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.86219081 |
| 46 | Focal adhesion_Homo sapiens_hsa04510 | 0.83151955 |
| 47 | Phototransduction_Homo sapiens_hsa04744 | 0.81316443 |
| 48 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.78018613 |
| 49 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.77586324 |
| 50 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.75036672 |
| 51 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.71857619 |
| 52 | Ribosome_Homo sapiens_hsa03010 | 0.71471283 |
| 53 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.70842771 |
| 54 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.70468915 |
| 55 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70069345 |
| 56 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.70003871 |
| 57 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.64512908 |
| 58 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.64374739 |
| 59 | Renin secretion_Homo sapiens_hsa04924 | 0.59177289 |
| 60 | Insulin secretion_Homo sapiens_hsa04911 | 0.54031162 |
| 61 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.51408581 |
| 62 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44975529 |
| 63 | RNA degradation_Homo sapiens_hsa03018 | 0.41489240 |
| 64 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.41485996 |
| 65 | Salivary secretion_Homo sapiens_hsa04970 | 0.41068400 |
| 66 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.38992878 |
| 67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.38941705 |
| 68 | Platelet activation_Homo sapiens_hsa04611 | 0.38825307 |
| 69 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.38406677 |
| 70 | Olfactory transduction_Homo sapiens_hsa04740 | 0.36817243 |
| 71 | Long-term potentiation_Homo sapiens_hsa04720 | 0.36368989 |
| 72 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.36191363 |
| 73 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.36099940 |
| 74 | Lysine degradation_Homo sapiens_hsa00310 | 0.33626949 |
| 75 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32254553 |
| 76 | Amoebiasis_Homo sapiens_hsa05146 | 0.30756881 |
| 77 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.30469476 |
| 78 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.28991425 |
| 79 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.28839061 |
| 80 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.27453430 |
| 81 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.27138424 |
| 82 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.26316724 |
| 83 | Circadian entrainment_Homo sapiens_hsa04713 | 0.25037982 |
| 84 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.24990613 |
| 85 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.24829653 |
| 86 | Adherens junction_Homo sapiens_hsa04520 | 0.22320077 |
| 87 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.22162506 |
| 88 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.21792022 |
| 89 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.21626251 |
| 90 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.20501076 |
| 91 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.19272075 |
| 92 | Peroxisome_Homo sapiens_hsa04146 | 0.19244829 |
| 93 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.18583595 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.18437094 |
| 95 | ABC transporters_Homo sapiens_hsa02010 | 0.18094291 |
| 96 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.17986079 |
| 97 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.17935754 |
| 98 | RNA polymerase_Homo sapiens_hsa03020 | 0.17128223 |
| 99 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.16280128 |
| 100 | Metabolic pathways_Homo sapiens_hsa01100 | 0.15530423 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15376010 |
| 102 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.15161340 |
| 103 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.15054980 |
| 104 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.15049863 |
| 105 | Other glycan degradation_Homo sapiens_hsa00511 | 0.14745515 |
| 106 | Purine metabolism_Homo sapiens_hsa00230 | 0.14488401 |
| 107 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.13553861 |
| 108 | Histidine metabolism_Homo sapiens_hsa00340 | 0.12876782 |
| 109 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.12395389 |
| 110 | Long-term depression_Homo sapiens_hsa04730 | 0.12260804 |
| 111 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.11515375 |
| 112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.11468022 |
| 113 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.11438607 |
| 114 | Sulfur relay system_Homo sapiens_hsa04122 | 0.10876547 |
| 115 | Legionellosis_Homo sapiens_hsa05134 | 0.10654869 |
| 116 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.09672445 |
| 117 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.08556499 |
| 118 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.08383123 |
| 119 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.08240167 |
| 120 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.08075352 |
| 121 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.06034320 |
| 122 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.05351861 |
| 123 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.03286543 |

